This is a big, CBD-rich plant for outdoor cultivation. CBD content is approximately 12 - 14%, depending on local conditions, while THC is below 0.3%. This latter figure means that it is perfectly legal to grow in both Italy and Switzerland.
It was created by crossing high-CBD strain Compolti with a Lemon Kush male plant. Plants grow very large and can reach a height of 300 - 400 cm. producing as much as 3000 gr/plant in a 9 - 10 week flowering period. Its inter-nodal length is such that the buds join up to form long colas. This strain has a rich terpene profile The terpene profile with Myrcene providing scents of musk, herbs and citrus while Linalool gives it some attractive floral notes of lavender.
The effect is said to be well-balanced and calming.
- Breeder/Brand Tiger One Bulk
- Product Type Seeds THC
- Genetics Compolti x Lemon Kush
- Pack Size 100 Seeds
- Flowering Type Photoperiod
- Sex Feminised
- THC Content <0.3%
- CBD Content 14 - 16%
- Yield Up to 3000 gr/plant
- Plant Height 300 - 400 cm
- Grows Grows outdoors
- Flowering Time 63 - 70 days
- Taste / Flavour Citrus, Lavender, Musky, Spicy / Herbal
- Effect Balanced, Calming
Strain FAQ
What gives some cannabis strains a musky smell?
Plant terpenes give it a musky smell. These strains smell earthy and rich thanks to terpenes like myrcene, humulene, caryophyllene, and linalool. Myrcene contributes to rich, earthy odours like forest floors and woods.
Is THC the only important element in cannabis?
No! The cannabinoids and terpenes of low-THC strains work together like the characters of a great film, reportedly improving the overall experience. There is no one most important element in cannabis and it is a combination of everything that comes together to provide the end result. We are excited to see what we learn as research continues!
How will cannabis therapy evolve?
With so many strains and pharmacological characteristics, personalised cannabis treatment has a bright future. Patients and doctors will likely soon be able to choose strains that are said to target their ailments, enabling more personalised cannabis therapy.